Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2011 Publisher: Ferring Pharmaceuticals Ltd., Drayton Hall, Church Road, West Drayton, UB7 7PS, United Kingdom
OCTIM Nasal Spray.
| Pharmaceutical Form |
|---|
|
Nasal Spray, Solution. Clear, colourless solution. |
Desmopressin acetate 150 micrograms per actuation.
For excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Desmopressin |
Desmopressin is a structural analogue of vasopressin in which the antidiuretic activity has been enhanced by the order of 10, while the vasopressor effect has been reduced by the order of 1500. The clinical advantage of this highly changed ratio of antidiuretic to vasopressor effect is that clinically active antidiuretic doses are far below the threshold for a vasopressor effect. |
| List of Excipients |
|---|
|
Sodium chloride |
Multidose container, Type I glass vial with a pre-compression pump set comprising of a spray pump with a metering valve, nasal applicator and protection cap.
Pack size: 2.5ml (25 sprays).
Ferring Pharmaceuticals Ltd., Drayton Hall, Church Road, West Drayton, UB7 7PS, United Kingdom
PL 03194/0056
25th October 2002
| Drug | Countries | |
|---|---|---|
| OCTIM | France, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
